Create your personalized pageChoose from the widgets below to add to your private page

Online Drugs Expert: Prescription Drug Information, Side Effects & Medicine Inte

New Tab

JavaScript must be enabled in order for you to use Netvibes.
However, it seems JavaScript is either disabled or not supported by your browser.
To use Netvibes, enable JavaScript by changing your browser options, then try again.

pharmacy's activitiespharmacy's friends activitiespharmacy's followers activitiespharmacy's friendspharmacy's followersGeneral

Netvibes - Pharmacy Expert

Drugs.com - New Drug Approvals

Dyax Announces FDA Approval of Kalbitor (ecallantide) for the Treatment of Acute Attacks of Hereditary Angioedema in Patients 16 Years of Age and Older - 2 days ago

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec 1, 2009 - Dyax Corp. announced today that the U.S. Food and...
FDA Approves 10 mcg Dose of Vagifem for the Treatment of Atrophic Vaginitis Due to Menopause - 2 days ago

PRINCETON, N.J., Dec. 2 /PRNewswire-FirstCall/ -- Novo Nordisk said today that the U.S. Food and...
FDA Approves OTC Version Of Heartburn Drug Zegerid - 2 days ago

WHITEHOUSE STATION, N.J.--Merck & Co. and Santarus Inc. said Tuesday the Food and Drug...

Online Drugs Expert: Prescription Drug Information, Side Effects & Medicine Inte

Netvibes - Pharmacy Expert

Drugs.com - New Drug Approvals

Dyax Announces FDA Approval of Kalbitor (ecallantide) for the Treatment of Acute Attacks of Hereditary Angioedema in Patients 16 Years of Age and Older - 2 days ago

FDA Approves 10 mcg Dose of Vagifem for the Treatment of Atrophic Vaginitis Due to Menopause - 2 days ago

FDA Approves OTC Version Of Heartburn Drug Zegerid - 2 days ago

About Netvibes

Explore

Business

Platform

Help